Cargando…
Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947784/ https://www.ncbi.nlm.nih.gov/pubmed/35350718 http://dx.doi.org/10.1093/rap/rkac009 |
| _version_ | 1784674521408602112 |
|---|---|
| author | Lever, Elliott Colquhoun, Matthew Flora, Kalveer El-Ghazali, Shawki Baslas, Rohit Suleman, Yasir Wieckowski, Amy Farah, Ziad Hamdulay, Shahir Isaacs, Anthony Mukherjee, Jaita Pazos, Francis Penn, Henry Machado, Pedro M |
| author_facet | Lever, Elliott Colquhoun, Matthew Flora, Kalveer El-Ghazali, Shawki Baslas, Rohit Suleman, Yasir Wieckowski, Amy Farah, Ziad Hamdulay, Shahir Isaacs, Anthony Mukherjee, Jaita Pazos, Francis Penn, Henry Machado, Pedro M |
| author_sort | Lever, Elliott |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8947784 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89477842022-03-28 Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence Lever, Elliott Colquhoun, Matthew Flora, Kalveer El-Ghazali, Shawki Baslas, Rohit Suleman, Yasir Wieckowski, Amy Farah, Ziad Hamdulay, Shahir Isaacs, Anthony Mukherjee, Jaita Pazos, Francis Penn, Henry Machado, Pedro M Rheumatol Adv Pract Letter to the Editor (Other) Oxford University Press 2022-03-10 /pmc/articles/PMC8947784/ /pubmed/35350718 http://dx.doi.org/10.1093/rap/rkac009 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor (Other) Lever, Elliott Colquhoun, Matthew Flora, Kalveer El-Ghazali, Shawki Baslas, Rohit Suleman, Yasir Wieckowski, Amy Farah, Ziad Hamdulay, Shahir Isaacs, Anthony Mukherjee, Jaita Pazos, Francis Penn, Henry Machado, Pedro M Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence |
| title | Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence |
| title_full | Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence |
| title_fullStr | Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence |
| title_full_unstemmed | Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence |
| title_short | Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence |
| title_sort | rituximab in rheumatology: single-centre sars-cov-2 infection and covid-19 prevalence |
| topic | Letter to the Editor (Other) |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947784/ https://www.ncbi.nlm.nih.gov/pubmed/35350718 http://dx.doi.org/10.1093/rap/rkac009 |
| work_keys_str_mv | AT leverelliott rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT colquhounmatthew rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT florakalveer rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT elghazalishawki rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT baslasrohit rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT sulemanyasir rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT wieckowskiamy rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT farahziad rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT hamdulayshahir rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT isaacsanthony rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT mukherjeejaita rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT pazosfrancis rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT pennhenry rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence AT machadopedrom rituximabinrheumatologysinglecentresarscov2infectionandcovid19prevalence |